Categories

About IVD

Key Genetic Markers Linked with Ankylosing Spondylitis Key Genetic Markers Linked with Ankylosing Spondylitis
About IVD
More
HLA-B27: A Key Genetic Marker in Ankylosing Spondylitis and Related Disorders HLA-B27: A Key Genetic Marker in Ankylosing Spondylitis and Related Disorders
About IVD
More
Detecting the Factor V G1691A Mutation – Precision for Thrombophilia Risk Assessment Detecting the Factor V G1691A Mutation – Precision for Thrombophilia Risk Assessment
About IVD
More
Precision in Anticoagulant Therapy: The Role of Genotyping in Warfarin Treatment Precision in Anticoagulant Therapy: The Role of Genotyping in Warfarin Treatment
About IVD
More
ApoE genetic testing – a tool to prevent side effects during Lecanemab/Leqembi® treatment ApoE genetic testing – a tool to prevent side effects during Lecanemab/Leqembi® treatment
About IVDTesting
More
The European Medicines Agency (EMA) recommends dihydropyrimidine dehydrogenase testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine The European Medicines Agency (EMA) recommends dihydropyrimidine dehydrogenase testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
About IVDTesting
More
CYP2A6 Genotyping for Anticancer Investigational Drug Pharmacogenetic Assessment CYP2A6 Genotyping for Anticancer Investigational Drug Pharmacogenetic Assessment
About IVDTesting
More